Industrial Machinery & Robotics Global On demand · 24-48h

Global Laboratory Automation Robot Systems Market Strategic Research Report

Global Laboratory Automation Robot Systems Market Strategic …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Laboratory Automation Robot Systems Market
$2.68B2025
7.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single-Step Automation, Multi-Step Workstation Automation, Multi-Instrument Workcell Automation, Lab-Wide Integrated Automation

By Application: Drug Discovery and Screening, Genomics and Molecular Biology, Cell Biology and Bioprocessing, Clinical and Diagnostic Testing, Analytical Testing and Quality Control, Materials and Chemical R&D

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Tecan, Hamilton, Beckman Coulter Life Sciences, Agilent Technologies, Revvity, HighRes Biosolutions, SPT Labtech, Opentrons, Biosero, Automata, Hudson Robotics, BioNex Solutions, Peak Analysis & Automation, Chemspeed Technologies, Labman Automation, MegaRobo, Bioyond, XImaging, RayKol, Robotic Biology Institute

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 146 pages
Market size 2025
$2.68B
Billion USD
Forecast CAGR
7.4%
2025-2032
Forecast 2032
$4.4B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Laboratory Automation Robot Systems market size is predicted to grow from US$ 2,680 million in 2025 to US$ 4,398 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Laboratory automation robot systems combine liquid-handling or sample-transport robots, robotic arms, track or mobile platforms, instrument interfaces, scheduling software, and data-management modules to execute pipetting, dispensing, mixing, incubation, analysis, sample transfer, and result recording through predefined or adaptive workflows. Key procurement criteria include throughput, repeatability, precision, device compatibility, exception handling, and walk-away operation. Systems are typically delivered as standalone workstations, integrated workcells, or lab-wide platforms. The blended gross margin is approximately 45%.

Demand is driven by drug discovery, high-throughput screening, omics research, cell and gene therapy development, clinical testing, and quality control. Rising workflow volumes, greater sample-processing complexity, shortages of experienced laboratory staff, and stricter requirements for consistency and end-to-end traceability are accelerating the shift from manual operations to automated and walk-away laboratories.

Product architectures are moving from standalone liquid-handling or transport devices toward modular workstations, multi-instrument robotic workcells, and lab-wide orchestration platforms. Machine vision, force control, exception recovery, digital twins, open interfaces, and AI-assisted scheduling are becoming important differentiators. Established global vendors retain advantages in liquid handling, device-driver libraries, and validation of large integrated systems, while newer suppliers compete through open architectures, modular deployment, lower retrofit costs, and localized service.

North America and Europe remain the main purchasing regions for high-end integrated systems, while adoption in Asia is expanding with investment in biopharmaceutical research, testing laboratories, and materials R&D. Opportunities are strongest in rapidly deployable standardized workcells, cross-vendor device connectivity, and workflow-specific hardware-software solutions. Key risks include high initial investment, lengthy method-transfer and validation cycles, inconsistent device interfaces, and insufficient project-delivery or after-sales capabilities.

Report Scope

Key Questions Addressed in this Report

What is the 10-year outlook for the global Laboratory Automation Robot Systems market?

What factors are driving Laboratory Automation Robot Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Laboratory Automation Robot Systems market opportunities vary by end market size?

How does Laboratory Automation Robot Systems break out by Type, by Application?

This report presents a comprehensive overview of the global Laboratory Automation Robot Systems market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single-Step Automation
  • Multi-Step Workstation Automation
  • Multi-Instrument Workcell Automation
  • Lab-Wide Integrated Automation

Segment by Robot Architecture

  • Gantry Robot Systems
  • Articulated Arm Systems
  • Track-Based Transport Systems
  • Autonomous Mobile Robot Systems
  • Hybrid Robot Systems

Segment by Throughput Level

  • Low-Throughput Systems
  • Medium-Throughput Systems
  • High-Throughput Systems

Segment by System Openness

  • Closed Proprietary Systems
  • Vendor-Specific Modular Systems
  • Multi-Vendor Integrated Systems
  • Open Device-Agnostic Systems

Segment by Application

  • Drug Discovery and Screening
  • Genomics and Molecular Biology
  • Cell Biology and Bioprocessing
  • Clinical and Diagnostic Testing
  • Analytical Testing and Quality Control
  • Materials and Chemical R&D

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Laboratory Automation Robot Systems market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Drug Discovery and Screening, Genomics and Molecular Biology, Cell Biology and Bioprocessing evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Laboratory Automation Robot Systems Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.68B
2025
Forecast
$4.4B
2032
CAGR
7.4%
2025–2032
Régions
5
global
Key companies
Thermo Fisher ScientificTecanHamiltonBeckman Coulter Life SciencesAgilent TechnologiesRevvityHighRes BiosolutionsSPT Labtech
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single-Step AutomationMulti-Step Workstation AutomationMulti-Instrument Workcell AutomationLab-Wide Integrated Automation
By Application
Drug Discovery and ScreeningGenomics and Molecular BiologyCell Biology and BioprocessingClinical and Diagnostic TestingAnalytical Testing and Quality ControlMaterials and Chemical R&D

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single-Step Automation
  • 3.1.3 Multi-Step Workstation Automation
  • 3.1.4 Multi-Instrument Workcell Automation
  • 3.1.5 Lab-Wide Integrated Automation
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Drug Discovery and Screening
  • 4.1.3 Genomics and Molecular Biology
  • 4.1.4 Cell Biology and Bioprocessing
  • 4.1.5 Clinical and Diagnostic Testing
  • 4.1.6 Analytical Testing and Quality Control
  • 4.1.7 Materials and Chemical R&D
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Tecan
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Hamilton
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Beckman Coulter Life Sciences
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Agilent Technologies
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Revvity
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 HighRes Biosolutions
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 SPT Labtech
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Opentrons
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Biosero
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Automata
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Hudson Robotics
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 BioNex Solutions
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Peak Analysis & Automation
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Chemspeed Technologies
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Labman Automation
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 MegaRobo
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Bioyond
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 XImaging
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 RayKol
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Robotic Biology Institute
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Laboratory Automation Robot Systems market?
The global Laboratory Automation Robot Systems market is estimated at US$ 2.68 billion in 2025 (base year) and is projected to reach US$ 4.4 billion by 2032.
How fast is the Laboratory Automation Robot Systems market expected to grow?
The market is expected to grow at a CAGR of 7.4% from 2026 to 2032, expanding from US$ 2.68 billion in 2025 to US$ 4.4 billion in 2032, roughly 1.6 times its base-year value.
What does the Laboratory Automation Robot Systems market cover?
Laboratory automation robot systems combine liquid-handling or sample-transport robots, robotic arms, track or mobile platforms, instrument interfaces, scheduling software, and data-management modules to execute pipetting, dispensing, mixing, incubation, analysis, sample transfer, and result recording through predefined or adaptive workflows. Key procurement criteria include throughput, repeatability, precision, device compatibility, exception handling, and walk-away operation.
What are the main segments of the Laboratory Automation Robot Systems market by type?
By type, the market is segmented into Single-Step Automation, Multi-Step Workstation Automation, Multi-Instrument Workcell Automation and Lab-Wide Integrated Automation.
Which applications drive demand in the Laboratory Automation Robot Systems market?
Key applications covered include Drug Discovery and Screening, Genomics and Molecular Biology, Cell Biology and Bioprocessing, Clinical and Diagnostic Testing, Analytical Testing and Quality Control and Materials and Chemical R&D.
Who are the key players in the Laboratory Automation Robot Systems market?
Key players profiled include Thermo Fisher Scientific, Tecan, Hamilton, Beckman Coulter Life Sciences, Agilent Technologies, Revvity, HighRes Biosolutions and SPT Labtech, among 21 companies covered in total.
Which regions and countries are covered for Laboratory Automation Robot Systems?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Laboratory Automation Robot Systems market?
Demand is driven by drug discovery, high-throughput screening, omics research, cell and gene therapy development, clinical testing, and quality control.
Who should buy the Laboratory Automation Robot Systems market report?
The report is intended for manufacturers and solution providers, distributors and end users in Drug Discovery and Screening, Genomics and Molecular Biology and Cell Biology and Bioprocessing, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Laboratory Automation Robot Systems market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.